133 related articles for article (PubMed ID: 38659485)
1. Inhibition of hepatitis B virus
Ge FL; Yang Y; Si LL; Li YH; Cao MZ; Wang J; Bai ZF; Ren ZG; Xiao XH; Liu Y
World J Gastroenterol; 2024 Apr; 30(13):1911-1925. PubMed ID: 38659485
[TBL] [Abstract][Full Text] [Related]
2. Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV)
Ge FL; Si LL; Yang Y; Li YH; Lv ZL; Liu WH; Liao H; Wang J; Zou J; Li L; Li H; Zhang ZL; Wang JB; Lu XC; Xu DP; Bai ZF; Liu Y; Xiao XH
Front Pharmacol; 2021; 12():756975. PubMed ID: 34776974
[TBL] [Abstract][Full Text] [Related]
3. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
Liu Y; Yao W; Si L; Hou J; Wang J; Xu Z; Li W; Chen J; Li R; Li P; Bo L; Xiao X; Lan J; Xu D
Antiviral Res; 2018 Jul; 155():39-47. PubMed ID: 29702120
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
He W; Li LX; Liao QJ; Liu CL; Chen XL
World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
[TBL] [Abstract][Full Text] [Related]
5. Liuweiwuling Tablet relieves the inflammatory transformation of hepatocellular carcinoma by inhibiting the PI3K/AKT/NF-κB signaling pathway.
Chen Y; Song Z; Hou X; Liu J; Zheng C; Zhao X; Lv G; Li J; Xiu Y; Shi W; Zhao J; Yang H; Wang Y; Zhao J; Zhan X; Niu M; Zou W; Bai Z; Xiao X
J Ethnopharmacol; 2024 Mar; 321():117406. PubMed ID: 37952733
[TBL] [Abstract][Full Text] [Related]
6. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK/STAT signal pathway.
Wang T; Wang X; Zhuo Y; Si C; Yang L; Meng L; Zhu B
J Ethnopharmacol; 2020 Jul; 257():112782. PubMed ID: 32217096
[TBL] [Abstract][Full Text] [Related]
8. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
[TBL] [Abstract][Full Text] [Related]
9. Total saponins extracted from Abrus cantoniensis Hance suppress hepatitis B virus replication in vitro and in rAAV8-1.3HBV transfected mice.
Yao X; Li Z; Gong X; Fu X; Xiao X; He M; Huang B; Xu Z
J Ethnopharmacol; 2020 Mar; 249():112366. PubMed ID: 31678415
[TBL] [Abstract][Full Text] [Related]
10. [Study on mechanism of Chinese Yam polysaccharide synergizing nucleoside analogues against hepatitis B virus through p38 MAPK signaling pathway].
Li CY; Wu ZH; Zheng Y; Li B; Zhang JC; Lu LX; Xie XQ; He YJ; Yu XH
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2776-2782. PubMed ID: 38812178
[TBL] [Abstract][Full Text] [Related]
11. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment.
Shi H; Lu L; Zhang NP; Zhang SC; Shen XZ
World J Gastroenterol; 2012 Jul; 18(27):3617-22. PubMed ID: 22826629
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation.
Tanaka T; Okuyama-Dobashi K; Murakami S; Chen W; Okamoto T; Ueda K; Hosoya T; Matsuura Y; Ryo A; Tanaka Y; Hagiwara M; Moriishi K
Antiviral Res; 2016 Sep; 133():156-64. PubMed ID: 27515132
[TBL] [Abstract][Full Text] [Related]
13. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
Yang Q; Zhao X; Zang L; Fang X; Zhao J; Yang X; Wang Q; Zheng L; Chang J
Antiviral Res; 2012 Dec; 96(3):333-9. PubMed ID: 23098744
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells.
Cui X; Inagaki Y; Xu H; Wang D; Qi F; Kokudo N; Fang D; Tang W
Biol Pharm Bull; 2010; 33(10):1728-32. PubMed ID: 20930383
[TBL] [Abstract][Full Text] [Related]
15. Blocking neddylation elicits antiviral effect against hepatitis B virus replication.
Abounouh K; Kayesh MEH; Altawalah H; Kitab B; Murakami S; Ogawa S; Tanaka Y; Dehbi H; Pineau P; Kohara M; Benjelloun S; Tsukiyama-Kohara K; Ezzikouri S
Mol Biol Rep; 2022 Jan; 49(1):403-412. PubMed ID: 34716866
[TBL] [Abstract][Full Text] [Related]
16. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
König A; Yang J; Jo E; Park KHP; Kim H; Than TT; Song X; Qi X; Dai X; Park S; Shum D; Ryu WS; Kim JH; Yoon SK; Park JY; Ahn SH; Han KH; Gerlich WH; Windisch MP
J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792
[TBL] [Abstract][Full Text] [Related]
17. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
Delaney WE; Miller TG; Isom HC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis B virus activity of chickweed [Stellaria media (L.) Vill.] extracts in HepG2.2.15 cells.
Ma L; Song J; Shi Y; Wang C; Chen B; Xie D; Jia X
Molecules; 2012 Jul; 17(7):8633-46. PubMed ID: 22810196
[TBL] [Abstract][Full Text] [Related]
19. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
Hu K; Huang Y; Mu J; Cheng Z; Zhu X
Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
[TBL] [Abstract][Full Text] [Related]
20. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]